Switch theme
Sign up to access all valuation multiples
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals.
2002
84
LTM Revenue $5.8M
LTM EBITDA -$10.4M
$128M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nightingale Health has a last 12-month revenue (LTM) of $5.8M and a last 12-month EBITDA of -$10.4M.
In the most recent fiscal year, Nightingale Health achieved revenue of $4.9M and an EBITDA of -$10.3M.
Nightingale Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nightingale Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $5.8M | XXX | $4.9M | XXX | XXX | XXX |
| Gross Profit | $5.8M | XXX | $3.3M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 66% | XXX | XXX | XXX |
| EBITDA | -$10.4M | XXX | -$10.3M | XXX | XXX | XXX |
| EBITDA Margin | -180% | XXX | -211% | XXX | XXX | XXX |
| EBIT | -$19.5M | XXX | -$20.9M | XXX | XXX | XXX |
| EBIT Margin | -339% | XXX | -428% | XXX | XXX | XXX |
| Net Profit | -$19.5M | XXX | -$19.6M | XXX | XXX | XXX |
| Net Margin | -339% | XXX | -401% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nightingale Health's stock price is EUR 3 (or $3).
Nightingale Health has current market cap of EUR 172M (or $193M), and EV of EUR 114M (or $128M).
See Nightingale Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $128M | $193M | XXX | XXX | XXX | XXX | $-0.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nightingale Health has market cap of $193M and EV of $128M.
Nightingale Health's trades at 23.8x EV/Revenue multiple, and -12.4x EV/EBITDA.
Equity research analysts estimate Nightingale Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nightingale Health has a P/E ratio of -9.9x.
See valuation multiples for Nightingale Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $193M | XXX | $193M | XXX | XXX | XXX |
| EV (current) | $128M | XXX | $128M | XXX | XXX | XXX |
| EV/Revenue | 22.2x | XXX | 23.8x | XXX | XXX | XXX |
| EV/EBITDA | -12.3x | XXX | -12.4x | XXX | XXX | XXX |
| EV/EBIT | -6.5x | XXX | -6.3x | XXX | XXX | XXX |
| EV/Gross Profit | 22.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | -9.9x | XXX | -9.7x | XXX | XXX | XXX |
| EV/FCF | -6.7x | XXX | -9.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNightingale Health's last 12 month revenue growth is 55%
Nightingale Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Nightingale Health's rule of 40 is -186% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nightingale Health's rule of X is -41% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nightingale Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 55% | XXX | 50% | XXX | XXX | XXX |
| EBITDA Margin | -180% | XXX | -192% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -186% | XXX | -136% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -41% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 494% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nightingale Health acquired XXX companies to date.
Last acquisition by Nightingale Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Nightingale Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nightingale Health founded? | Nightingale Health was founded in 2002. |
| Where is Nightingale Health headquartered? | Nightingale Health is headquartered in Finland. |
| How many employees does Nightingale Health have? | As of today, Nightingale Health has 84 employees. |
| Who is the CEO of Nightingale Health? | Nightingale Health's CEO is Mr. Teemu Suna. |
| Is Nightingale Health publicy listed? | Yes, Nightingale Health is a public company listed on HEL. |
| What is the stock symbol of Nightingale Health? | Nightingale Health trades under HEALTH ticker. |
| When did Nightingale Health go public? | Nightingale Health went public in 2021. |
| Who are competitors of Nightingale Health? | Similar companies to Nightingale Health include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
| What is the current market cap of Nightingale Health? | Nightingale Health's current market cap is $193M |
| What is the current revenue of Nightingale Health? | Nightingale Health's last 12 months revenue is $5.8M. |
| What is the current revenue growth of Nightingale Health? | Nightingale Health revenue growth (NTM/LTM) is 55%. |
| What is the current EV/Revenue multiple of Nightingale Health? | Current revenue multiple of Nightingale Health is 22.2x. |
| Is Nightingale Health profitable? | Yes, Nightingale Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nightingale Health? | Nightingale Health's last 12 months EBITDA is -$10.4M. |
| What is Nightingale Health's EBITDA margin? | Nightingale Health's last 12 months EBITDA margin is -180%. |
| What is the current EV/EBITDA multiple of Nightingale Health? | Current EBITDA multiple of Nightingale Health is -12.3x. |
| What is the current FCF of Nightingale Health? | Nightingale Health's last 12 months FCF is -$19.1M. |
| What is Nightingale Health's FCF margin? | Nightingale Health's last 12 months FCF margin is -331%. |
| What is the current EV/FCF multiple of Nightingale Health? | Current FCF multiple of Nightingale Health is -6.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
